Lazard recent initiatives appear close to "hitting an inflection" and provide "reasons to add exposure to the stock." ...
Lazard (LAZ) at Buy, citing record M&A outlook, falling rates and ample credit; Piper Sandler (PIPR) Underperform.
Lazard Developing Markets Equity Portfolio underperformed its benchmark despite gains in Latin America. Review the full performance commentary and outlook now.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results